Patent Assignment
Reel/Frame 019699/0014
Assignment of Assignor's Interest
Recorded: 2007-08-15
Pages: 9
Assignor
IBIS BIOSCIENCES, INC.
Executed: 2007-08-15
Assignee
ISIS PHARMACEUTICALS, INC.
1896 RUTHERFORD ROAD, CARLSBAD, CALIFORNIA, 92008
Covered Properties
(22)
Oligoribonucleotide Assay for Novel Antibiotics
Application:
08/294,450 →
Oligoribonucleotide Assays for Novel Antibiotics
Patent:
5,712,096 →
Application:
08/498,402 →
Generation of Combinatorial Libraries of Compounds Corresponding to Virtual Libraries of Compounds
Application:
09/076,214 →
In Situ Binary Synthesis of Biologically Effective Molecules
Patent:
6,492,111 →
Application:
09/200,107 →
Identification of Disease Predictive Nucleic Acids
Patent:
6,451,524 →
Application:
09/200,355 →
Molecular Interaction Sites of Interleukin-2 Rna and Methods of Modulating the Same
Patent:
6,969,763 →
Application:
09/310,844 →
Molecular Interaction Sites Vimentin Rna and Methods of Modulating the Same
Application:
09/310,907 →
System and Method for Sample Positioning in a Robotic System
Patent:
6,429,016 →
Application:
09/411,748 →
Self-Dispensing Storage Device
Patent:
6,911,181 →
Application:
09/678,434 →
A Method of Identifying in silico Each Compound of a Virtual Library.
Application:
09/753,869 →
Publication:
US 2001/0018645
Identification of disease predictive nucleic acids
Application:
10/109,213 →
Publication:
US 2002/0168670
Molecular interaction sites of vimentin RNA and methods of modulating the same
Application:
10/135,017 →
Publication:
US 2003/0083483
System and method for sample positioning in a robotic system
Application:
10/153,327 →
Publication:
US 2002/0146347
In situ binary synthesis of biologically effective molecules
Application:
10/209,761 →
Publication:
US 2002/0192700
Small Molecule Targeting of Rna Structures
Application:
60/085,092 →
Identification of Disease Predictive Nucleic Acids
Application:
60/110,024 →
Molecular interaction sites of 16S ribosomal RNA and methods of modulating the same
Application:
60/313,890 →
Molecular interaction sites of RNase P RNA and methods of modulating the same
Application:
60/314,020 →
Molecular interaction sites of hepatitis C virus RNA and methods of modulating the same
Application:
60/314,236 →
Molecular interaction sites of 23S ribosomal RNA and methods of modulating the same
Application:
60/314,251 →
Computational determination of alternative splicing
Application:
60/379,229 →
Discovery of RNA structural elements using evolutionary computation
Application:
60/387,342 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 26, 1996
From: STERN, SETH; PUROHIT, PRAKASH
To: UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER
Reel/Frame 007802/0870 →
Assignment of Assignor's Interest
Mar 11, 1998
From: STERN, SETH; PUROHIT, PRAKASH
To: MASSACHUSETTS, UNIVERSITY OF
Reel/Frame 009038/0214 →
Confirmatory License
Nov 25, 1998
From: MASSACHUSETTS, UNIVERSITY OF
To: NATIONAL INSTITUTES OF HEALTH, THE
Reel/Frame 009648/0927 →
Assignment of Assignor's Interest
Nov 30, 1998
From: CROOKE, STANLEY T.; ECKER, DAVID J.; GRIFFEY, RICHARD; SWAYZE, ERIC
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 009613/0738 →
Assignment of Assignor's Interest
Nov 30, 1998
From: GRIFFEY, RICHARD; SWAYZE, ERIC
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 009613/0646 →
Assignment of Assignor's Interest
Mar 3, 1999
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 009789/0471 →
Assignment of Assignor's Interest
Aug 5, 1999
From: ECKER, DAVID J.; GRIFFEY, RICHARD; CROOKE, STANLEY T.; SAMPATH, RANGA
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 010143/0330 →
Assignment of Assignor's Interest
Aug 16, 1999
From: ECKER, DAVID J.; GRIFFEY, RICHARD; CROOKE, STANLEY T.; SAMPATH, RANGA
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 010168/0579 →
Assignment of Assignor's Interest
Oct 1, 1999
From: MCNEIL, JOHN
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 010295/0551 →
Assignment of Assignor's Interest
Oct 23, 2000
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 011196/0252 →
Assignment of Assignor's Interest
Feb 14, 2001
From: MCNEIL, JOHN
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 011539/0625 →
Assignment of Assignor's Interest
Aug 30, 2001
From: GRIFFEY, RICHARD; SWAYZE, ERIC
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 012121/0770 →
Assignment of Assignor's Interest
Oct 17, 2001
From: ECKER, DAVID J.
To: ISIS PHARAMACEUTICALS, INC.
Reel/Frame 012288/0578 →
Assignment of Assignor's Interest
Oct 19, 2001
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 012288/0048 →
Assignment of Assignor's Interest
Oct 19, 2001
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 012288/0051 →
Assignment of Assignor's Interest
Oct 19, 2001
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 012288/0059 →
Assignment of Assignor's Interest
Mar 27, 2002
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 012749/0486 →
Assignment of Assignor's Interest
Aug 5, 2002
From: ECKER, DAVID J.; GRIFFEY, RICHARD; CROOKE, STANLEY T.; SAMPATH, RANGA
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 013147/0830 →
Assignment of Assignor's Interest
Aug 16, 2002
From: SAMPATH, RANGARAJAN
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 013192/0420 →
Assignment of Assignor's Interest
Jan 7, 2003
From: SAMPATH, RANGARAJAN
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 013639/0835 →
Assignment: This Application Is Assigned of Record to Isis Pharmaceuticals, Inc., as Evidenced by the Assignment Filed at 010295, Frame 0551 in Parent Application Serial No. 09/411,748.
Jul 10, 2003
From: MCNEIL, JOHN
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 013789/0771 →
Assignment of Assignor's Interest
Jul 16, 2003
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 013805/0804 →
Assignment of Assignor's Interest
Aug 18, 2003
From: ECKER, DAVID J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 013883/0857 →
Assignment of Assignor's Interest
Aug 14, 2007
From: ISIS PHARMACEUTICALS, INC.
To: IBIS BIOSCIENCES, INC.
Reel/Frame 019690/0092 →
Assignment of Assignor's Interest
Aug 14, 2007
From: ISIS PHARMACEUTICALS, INC.
To: IBIS BIOSCIENCES, INC.
Reel/Frame 019690/0121 →